These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28264545)

  • 21. Botulinum toxin: a review of applications for the head and neck.
    Seidman LM; Brooks JK; Bashirelahi N
    Gen Dent; 2019; 67(2):55-58. PubMed ID: 30875307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the neuromuscular junction in skeletal muscles.
    Childers MK
    Am J Phys Med Rehabil; 2004 Oct; 83(10 Suppl):S38-44. PubMed ID: 15448576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anatomic localization of motor entry points and accurate regions for botulinum toxin injection in the flexor digitorum superficialis.
    Ye JF; Lee JH; An XC; Lin CH; Yue B; Han SH
    Surg Radiol Anat; 2011 Sep; 33(7):601-7. PubMed ID: 21258930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Out of the spasticity box: Off-label uses of botulinum toxin in children.
    Oleszek JL; Kanallakan AS; Powell AJ
    J Pediatr Rehabil Med; 2020; 13(2):205-207. PubMed ID: 32444580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion.
    Lim EC; Seet RC
    Acta Neurol Scand; 2008 Feb; 117(2):73-84. PubMed ID: 17850405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic use of botulinum A toxin in neurology].
    Schnider P; Schmied M; Berger T; Auff E
    Wien Klin Wochenschr; 1994; 106(11):335-44. PubMed ID: 8053201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin for rejuvenation of the neck.
    Brandt FS; Boker A
    Clin Dermatol; 2003; 21(6):513-20. PubMed ID: 14759585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor.
    Orbelo DM; Duffy JR; Hughes Borst BJ; Ekbom D; Maragos NE
    J Voice; 2014 Jan; 28(1):123-7. PubMed ID: 24080335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new possibility for focal treatment of spasticity with botulinum neurotoxin. The Danish Society of Neurology].
    Jeppesen LL; Dalager T; Meden P
    Ugeskr Laeger; 2004 Mar; 166(12):1117. PubMed ID: 15067776
    [No Abstract]   [Full Text] [Related]  

  • 31. Preoperative botulinum toxin test injections before muscle lengthening in cerebral palsy.
    Rutz E; Hofmann E; Brunner R
    J Orthop Sci; 2010 Sep; 15(5):647-53. PubMed ID: 20953926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Traditional pharmacological treatments for spasticity. Part I: Local treatments.
    Gracies JM; Elovic E; McGuire J; Simpson DM
    Muscle Nerve Suppl; 1997; 6():S61-91. PubMed ID: 9826983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological effects of botulinum toxin in spasticity.
    Gracies JM
    Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BTX-A has notable effects contradicting some treatment aims in the rat triceps surae compartment, which are not confined to the muscles injected.
    Yucesoy CA; Ateş F
    J Biomech; 2018 Jan; 66():78-85. PubMed ID: 29154085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group.
    Brin MF
    Muscle Nerve Suppl; 1997; 6():S208-20. PubMed ID: 9826992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding use of botulinum toxin.
    Bhidayasiri R; Truong DD
    J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to avoid complications when treating hyperdynamic folds and wrinkles.
    Sommer B
    Clin Dermatol; 2003; 21(6):521-3. PubMed ID: 14759586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to botulinum toxin F in seronegative botulinum toxin A--resistant patients.
    Greene PE; Fahn S
    Mov Disord; 1996 Mar; 11(2):181-4. PubMed ID: 8684389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin injections for the treatment of neurogenic thoracic outlet syndrome: A systematic review.
    Woodworth TT; Le A; Miller C; Conger A; Mahan MA; Cushman DM
    Muscle Nerve; 2024 Jul; 70(1):28-35. PubMed ID: 38529885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.